Case Studies
Drug discovery, development, and commercialization is like a puzzle. The end may be easy to visualize, but there are many pieces that need to be…
Articles
There’s an adage that says what gets measured gets improved. Regulatory submissions are no exception. And with the growing complexity of clinical trials and increasing…
Articles
Most people would agree that it’s better to prevent a crisis than to have to deal with one. But the reality is, by their nature,…
Video
Compliance challenges can create significant problems for life sciences organizations. Warning letters, consent decrees, product recalls, regulatory inspections, supply chain disruptions, and other crises have…
Articles
This article was originally published on MasterControl’s GxP Lifeline blog as How to Avoid—but Prepare for—Compliance Crises. What happens when a medical technology company gets…
Articles
Read the article below or download the complete PDF: "Don't Let a Crisis Become a Disaster" → When you hear “crisis,” you think “COVID.” But a…
Articles
Development of a novel therapeutic takes several years of intense research and detailed planning. Because target populations are likely to be distributed over multiple regions…
Articles
This article has been updated to indicate that the European Union Medical Device Regulation deadline has been extended one year, until May 26, 2021. According…
Articles
If you are confused by the many acronyms related to regulatory submissions, you are not alone. A variety of data from disparate functions must come…
Articles
By Susan Carino, Principal Consultant, and Ruba Hadidi, Project Management Consultant Integrated Project Management Company, Inc. (IPM) No matter your company size or phase of…